ADVFN US – Market Content Editor

Shares of Incyte Corporation (NASDAQ:INCY) rose 3.6% on Thursday after the biopharmaceutical firm named Bill Meury as its new President and Chief Executive Officer, effective immediately. Meury, a seasoned executive with more than 30 years in the pharmaceutical industry, takes over from Hervé Hoppenot, who is retiring after over a decade at the company’s helm.…

Shares of Cyngn Inc. (NASDAQ:CYN) surged over 130% after the company received a prominent mention in a NVIDIA (NASDAQ:NVDA) blog post, spotlighting its role in the development of autonomous industrial vehicles. The blog, which focused on robotics firms leveraging NVIDIA’s Isaac platform, featured Cyngn as one of the innovators using the technology to build advanced…

Walgreens Boots Alliance (NASDAQ:WBA) reported stronger-than-expected earnings and revenue for its fiscal third quarter, as cost-cutting measures helped offset weakness in front-of-store sales. The upbeat results come as the company prepares to transition from a public to private entity. The U.S.’s second-largest pharmacy chain is in the midst of a $10 billion buyout agreement with…

Altimmune Inc. (NASDAQ:ALT) saw its stock tumble by 37% after releasing topline data from its Phase 2b IMPACT trial evaluating pemvidutide for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). The biopharmaceutical company reported that the trial met its primary goal—up to 59.1% of patients achieved resolution of MASH without worsening fibrosis based on an intent-to-treat…

Pfizer Inc. (NYSE:PFE) announced encouraging results from its Phase 3 clinical trial of HYMPAVZI, a potential new treatment for patients with hemophilia A or B who develop inhibitors—a major complication that limits the effectiveness of standard therapies. The company stated that HYMPAVZI outperformed existing treatments, achieving a 93% reduction in annualized bleeding rates among trial…

Shares of Acuity Brands Inc. (NYSE:AYI) surged by almost 8% in Thursday’s pre-market session after the company posted fiscal third-quarter results that blew past Wall Street forecasts. The Atlanta-based firm, known for its lighting and smart building technology, reported adjusted earnings per share of $5.12, far above the $4.30 consensus estimate. Revenue also came in…

The U.S. dollar tumbled to its lowest level in over two years on Thursday amid renewed political attacks from former President Donald Trump against Federal Reserve Chair Jerome Powell, intensifying concerns over the Fed’s autonomy. By 08:30 GMT, the U.S. Dollar Index, which tracks the greenback against six major currencies, had slipped 0.6% to 96.682—a…

Micron Technology (NASDAQ:MU) saw its shares gain slightly in premarket U.S. trading Thursday after reporting robust third-quarter fiscal results and issuing positive guidance for the current quarter, driven by sustained demand for memory chips used in artificial intelligence applications. The company revealed a nearly 50% increase in sales of its high-bandwidth memory (HBM) chips compared…

Shares of Jefferies Financial Group Inc (NYSE:JEF) slipped 2.5% in after-hours trading following the announcement of mixed financial results for the second quarter of fiscal 2025. The investment bank posted net revenue of $1.63 billion, surpassing analyst estimates, but earnings per share came in slightly below expectations at $0.40 versus the forecasted $0.42. Net income…

Gold prices held their ground early Thursday in Asian trading, buoyed by a softer U.S. dollar after fresh political tensions surfaced between former President Donald Trump and Federal Reserve Chair Jerome Powell. The metal’s stability was also supported by a reduction in geopolitical risks following a ceasefire agreement between Israel and Iran. Spot gold remained…